Botulinum toxin type-A (BTXA) has been successfully used for treatment of cerebral palsy but has also demonstrated side effects that produce muscle atrophy, loss of strength, and loss of contractile material in target and non-target muscles. This study aims to examine if direct muscle stimulation training in conjunction with BTXA injections will reduce (possibly prevent) muscle atrophy, loss of strength and structural integrity in target and non-target muscles and vastly accelerate recovery of the target and non-target musculature to normal functional levels.


Most treatments for cerebral palsy (CP) are initially directed toward children. What is not clearly established is the long- term effects of such treatments. Many appear helpful in the short term but prove to be disadvantageous in the long run. Selective dorsal rhizotomy (SDR) is a permanent, irreversible neurosurgical procedure for reducing spasticity in cerebral palsy. Parents contemplating SDR for their child would like assurance that that there will not be harmful complications from it as the child ages into adolescence and adulthood. We now have new evidence...








Has there been a paper released yet on the findings of this study into BXTA trials?
a niece, Cassandra Tucker Peters, age 67 CP patient…
please lead us to learn more for her comfort at this time in her life…she has been very successful and active until these last five years…
Cassandra lives in Terre Haute, In and has taught the severely handicapped children for 30 years…has a BA and two MA degrees…her mother is still living at age 90…Cass has asked me to please try to make contact with any research she might contribute to or receive advice…Mary L. Hirt,